4-羟基-2,6-二甲基苯甲腈 pictrelisib CAS号957054-30-7分子式、结构式、MSDS、物化性质、用途-化学科研者一站式服务平台

化合物简介

GDC-0941 is a potent and selective oral inhibitor of the class I PI3K. GDC-0941 demonstrated broad spectrum of activity in breast, ovarian, lung, and prostate cancer models. Studies has also shown GDC-0941 may enhance anti-tumor activity of Docetaxel in human breast cancer models.

基本信息

CAS：957054-30-7
中文别名：2-(1H-吲唑-4-基)-6-[[4-(甲基磺酰基)-1-哌嗪基]甲基]-4-(4-吗啉基)噻吩并[3,2-d]嘧啶;
英文别名：GDC-0941;4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine;GDC-0941 bismesylate;Pictilisib;
分子式：C23H27N7O3S2
分子量：513.636
精确质量：513.162
Psa：144.17
Logp：3.17